| 1 |
Ahmed T. Biomaterial-based in vitro 3D modeling of glioblastoma multiforme. Cancer Pathogenesis and Therapy 2023. [DOI: 10.1016/j.cpt.2023.01.002] [Reference Citation Analysis]
|
| 2 |
Rani V, Prabhu A. In vitro blood brain barrier models: Molecular aspects and therapeutic strategies in glioma management. Curr Res Transl Med 2022;71:103376. [PMID: 36580825 DOI: 10.1016/j.retram.2022.103376] [Reference Citation Analysis]
|
| 3 |
Wanigasekara J, Cullen PJ, Bourke P, Tiwari B, Curtin JF. Advances in 3D culture systems for therapeutic discovery and development in brain cancer. Drug Discov Today 2022;28:103426. [PMID: 36332834 DOI: 10.1016/j.drudis.2022.103426] [Reference Citation Analysis]
|
| 4 |
Drakulic D, Schwirtlich M, Petrovic I, Mojsin M, Milivojevic M, Kovacevic-grujicic N, Stevanovic M. Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling Pathways in Glioblastoma. Cells 2022;11:2530. [DOI: 10.3390/cells11162530] [Reference Citation Analysis]
|
| 5 |
Rix J, Uckermann O, Kirsche K, Schackert G, Koch E, Kirsch M, Galli R. Correlation of biomechanics and cancer cell phenotype by combined Brillouin and Raman spectroscopy of U87-MG glioblastoma cells. J R Soc Interface 2022;19:20220209. [PMID: 35857926 DOI: 10.1098/rsif.2022.0209] [Reference Citation Analysis]
|
| 6 |
Bruns J, Egan T, Mercier P, Zustiak SP. Glioblastoma spheroid growth and chemotherapeutic responses in single and dual-stiffness hydrogels. Acta Biomater 2022:S1742-7061(22)00324-5. [PMID: 35659918 DOI: 10.1016/j.actbio.2022.05.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Leong SW, Tan SC, Norhayati MN, Monif M, Lee SY. Effectiveness of Bioinks and the Clinical Value of 3D Bioprinted Glioblastoma Models: A Systematic Review. Cancers (Basel) 2022;14:2149. [PMID: 35565282 DOI: 10.3390/cancers14092149] [Reference Citation Analysis]
|
| 8 |
Rix J, Uckermann O, Kirsche K, Schackert G, Koch E, Kirsch M, Galli R. Correlation of biomechanics and cancer cell phenotype by combined Brillouin and Raman spectroscopy of U87-MG glioblastoma cells.. [DOI: 10.1101/2022.03.09.483576] [Reference Citation Analysis]
|
| 9 |
Tondepu C, Karumbaiah L. Glycomaterials to Investigate the Functional Role of Aberrant Glycosylation in Glioblastoma. Adv Healthc Mater 2022;11:e2101956. [PMID: 34878733 DOI: 10.1002/adhm.202101956] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 10 |
Fabro F, Lamfers MLM, Leenstra S. Advancements, Challenges, and Future Directions in Tackling Glioblastoma Resistance to Small Kinase Inhibitors. Cancers (Basel) 2022;14:600. [PMID: 35158868 DOI: 10.3390/cancers14030600] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 11 |
Dragoj M, Stojkovska J, Jovanović Stojanov S, Obradović B, Pešić M. A 3D Biomimetic System for Testing Anticancer Drug Sensitivity. Methods in Molecular Biology 2022. [DOI: 10.1007/978-1-0716-2513-2_1] [Reference Citation Analysis]
|
| 12 |
Knock E, Julian LM. Building on a Solid Foundation: Adding Relevance and Reproducibility to Neurological Modeling Using Human Pluripotent Stem Cells. Front Cell Neurosci 2021;15:767457. [PMID: 34867204 DOI: 10.3389/fncel.2021.767457] [Reference Citation Analysis]
|
| 13 |
Dragoj M, Stojkovska J, Stanković T, Dinić J, Podolski-Renić A, Obradović B, Pešić M. Development and Validation of a Long-Term 3D Glioblastoma Cell Culture in Alginate Microfibers as a Novel Bio-Mimicking Model System for Preclinical Drug Testing. Brain Sci 2021;11:1025. [PMID: 34439644 DOI: 10.3390/brainsci11081025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
